US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sigyn Therapeutics Inc
(OP:
SIGY
)
0.0329
UNCHANGED
Delayed Quote
Updated: 9:43 AM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sigyn Therapeutics Inc
< Previous
1
2
3
4
Next >
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via
TheNewswire.com
Topics
Death
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce.
Via
TheNewswire.com
Topics
Death
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
February 18, 2025
The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation
Via
TheNewswire.com
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
SAN DIEGO, CA - March 5, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce.
Via
TheNewswire.com
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
The Exclusive Event Kicks-Off Tomorrow February 26th at 4pm Eastern
Via
TheNewswire.com
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
February 07, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference
February 05, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
February 04, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
January 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
January 29, 2025
SAN DIEGO, CA - January 29, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of blood purification technologies to treat life-threatening conditions,...
Via
TheNewswire.com
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
August 02, 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
May 15, 2024
Via
Investor Brand Network
Topics
Death
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
SAN DIEGO, CA - (NewMediaWire) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for...
Via
TheNewswire.com
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
May 07, 2024
Via
Investor Brand Network
Topics
Death
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
May 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
April 12, 2024
Via
Investor Brand Network
Topics
Death
Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
April 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Making Drugs Perform Better
March 27, 2024
Via
Investor Brand Network
Topics
Death
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges
March 20, 2024
Via
Investor Brand Network
Topics
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space
March 15, 2024
Via
Investor Brand Network
Topics
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference
March 05, 2024
Via
Investor Brand Network
Topics
Death
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
March 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
4
Next >
